Work

Effekter av tioeterfettsyrer på glukose- og lipidmetabolisme i muskel- og leverceller

Year: 2017
Type: dissertation
Abstract: Background: World Health Organization states that approximately 52 % of the adult population suffers from overweight or obesity in 2014. Overweight and obesity increases the risk of co-morbidities, among others elevated blood pressure, type II diabetes, insulin resistance, heart failure, sleep apnoea and dyslipidaemia. For this thesis, the energy metabolism of human liver and skeletal muscle cells was investigated following pre-treatment with tetradecyl thio acetic acid (TTA) analogues, substances that potentially may affect the development of obesity, insulin resistance and type II diabetes. Method: Skeletal muscle cells previously donated from healthy male volunteers, and a cell line from human carcinogenic liver, was used as models. The muscle cells were cultured and differentiated into multinucleated myotubes, and the hepatocytes were cultivated to approximately 80% confluence. Lipid and glucose metabolism was investigated using radiolabelled [1-14C] oleic acid and D-[14C (U)] glucose. The cells were incubated with the TTA analogues TTA, 1-triple TTA (1-t TTA) and 2-triple TTA (2-t TTA), respectively during the last 48 hours before trapping or harvesting for the hepatocytes, and during the last 96 hours of the differentiation period for the myotubes. The gene expression was investigated using quantitative polymerase chain reaction (qPCR). Results: A switch was seen in the metabolism in the liver cells; increased metabolism of oleic acid, and decreased metabolism of glucose, after pre-treatment with the TTA analogues. This switch was not observed in the skeletal muscle cells. The gene expression analysis showed a significant upregulation of pyruvate dehydrogenasekinase isoenzym 4 (PDK4) in both cell models, and of angiopoietinlike protein 4 (ANGPTL4), «Cluster of differentiation» 36/thrombospondin-receptor (CD36) and pyruvate kinase liver (PKL) in skeletal muscle cells. Conclusion: Our data suggest that TTA analogues may affect the metabolism of oleic acid and glucose in human liver cells by inducing a switch in substrate preference, with reduced glucose metabolism and increased oleic acid metabolism. The response appears to be dose-dependent. In human skeletal muscle cells, there were no apparent effects of TTA analogues on either glucose- or oleic acid metabolism. Further studies are required to confirm or reject this. The study showed that several genes associated with PPAR were significantly upregulated after pre-treatment with all three TTA analogues. In the myotubes ANGPTL4, CD36, carnitine palmitoyl transferase-1A (CPT1A) and PDK4 were upregulated, whereas only PDK4 was upregulated in the liver cells. We can conclude that the TTA analogues function as a PPAR ligand, but more attempts must be made to get a clearer idea of how.
Institution: University of Oslo
Language: Norwegian Nynorsk
Open Access status: green
OpenAlex ID: W2784103774
Cites: 66
Cited by:
Related to: 10